Navigation Links
ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
Date:6/17/2010

CONSHOHOCKEN, Pa., June 17 /PRNewswire/ -- ePharmaSolutions, a leading provider of clinical research technologies and niche clinical services, launches version 3.0 of its eMVR (Electronic Monitor Visit Report) application with new features to support online and offline completion of monitoring reports for traveling clinical research associates and integrations with leading CTMS systems.

"Our latest release provides study monitors with the option of completing monitor reports online or offline, more robust reporting, and CTMS integration points," stated Steven Beales, ePharmaSolutions' Vice President of Information Technology.

ePharmaSolutions' Clinical Trial Portal (CTP) is used by more than 200,000 clinical researchers in 107 countries to help accelerate and improve site feasibility, study training, site activation and patient enrollment.  CTP version 4.0 contains new functionality for sponsors that includes eMVR (Electronic Monitor Visit Report) to support the authoring, completion and submission of online and offline monitor trip reports with electronic signature.  The new version of eMVR allows study monitors to complete their site visit reports online or offline in Microsoft Word.  The offline reports can be submitted back to the eMVR and the data is pulled from the Word template back into the system.  The eMVR auto-populates visit reports, confirmation and follow-up letters, and carries all follow-up data from one report to either follow-up letters or future visit reports.  The eMVR includes a robust tracking and reporting system for study managers and integrates with leading CTMS systems.

"Our clients have been asking for an offline monitor visit report completion feature for some time and the market has not been responding in a timely enough manner," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Our development team did an excellent job building out these features into this release to support the global needs of our biopharmaceutical and CRO clients," Converse added.

ePharmaSolutions' Clinical Trial Portal (CTP) provides biopharmaceutical companies and CROs with a fully validated solution to help accelerate and improve study start-up and site management through a variety of "Site Friendly" components that include: site feasibility application (SFA), secure document exchange (SDE), safety letter distribution (SLD), electronic monitor visit reporting (eMVR), learning management system (LMS), and the patient recruitment manager (PRM).  Future plans in 2010 include the inclusion of a grant payment tracking application for sponsors/sites and integration of 80 million EMR records into its investigator database for improved decision support during the site selection process.

About ePharmaSolutions, Inc.

ePharmaSolutions is a leading provider of technology-based clinical services that help improve the way sites are selected, trained, activated and supported to start clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world and is headquartered in Philadelphia, Pennsylvania. For more information call 610-832-9915 or visit www.epharmasolutions.com.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
3. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
4. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
5. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
6. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
7. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
8. Premier Micronutrient Launches Supplement for Hearing Health
9. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the ... dependent on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from ... in fatal overdoses in male populations.(1) , The proportion of women using illicit drugs ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health ... British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition ... Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol treatment ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination ... and concern over nerve agents and the deadly use of chemical weapons. Many questions ... and how even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC ... North America, today announced it would be offering some it’s exclusive product line ... on crafting quality and unique baby clothing/feeding products, will team up with AMAZON ...
Breaking Medicine News(10 mins):